Federico Ricci

Federico Ricci

Università degli Studi di Roma Tor Vergata - Rome / Italy
Medical and Health Sciences / Ophthalmology
AD Scientific Index ID: 1802346
University of Rome Tor Vergata
person_outline Federico Ricci's MOST POPULAR ARTICLES
1-) Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double …JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ...The Lancet 399 (10326), 729-740, 20221882022
2-) Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...The Lancet 399 (10326), 741-755, 20221642022
3-) Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN studyC Prünte, F Fajnkuchen, S Mahmood, F Ricci, K Hatz, J Studnička, ...British Journal of Ophthalmology 100 (6), 787-795, 20161802016
4-) Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathyF Pichi, AP Ciardella, ET Cunningham Jr, M Morara, C Veronese, ...Retina 34 (2), 373-384, 20141762014
5-) Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration: a phase IIb, multicenter, randomized controlled trialGJ Jaffe, TA Ciulla, AP Ciardella, F Devin, PU Dugel, CM Eandi, ...Ophthalmology 124 (2), 224-234, 20171522017